New Senate bill to protect 340B program

Sen. Peter Welch (D-Vt.) has introduced  a bill that would ban pharmaceutical companies from restricting access to 340B drug pricing program discounts, according to a Sept. 11 press release shared with Becker's.

The legislation is a Senate version of the bill introduced by Rep. Doris Matsui (D-Calif.) that seeks to ensure drug companies cannot impose conditions on 340B discounts through pharmacy partners. Drug companies that violate these requirements would be subject to fines as high as $2 million per day. 

340B Health President and CEO Maureen Testoni praised the bill, stating that it helps combat drugmaker policies that harm patient care in safety-net hospitals. 

"We call on members of Congress … to support this crucial legislation for the benefit of the patients who have access to vital care and support because of 340B," said Ms. Testoni.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like